ADIPOQ and diabetes mellitus: The major findings of the present study were that there was a significant gradient decrease in serum concentrations of adiponectin across the three groups of subjects with different levels of glycemic tolerance (i.e. normal glucose tolerance, impaired fasting glucose, and diabetes).